We investigated whether the Surgery failed to monitor the lithium levels in Ms L’s blood in February 2025 following her discharge from hospital which resulted in a further admission due to lithium toxicity.
We also considered the Surgery’s prescribing of quetiapine to Ms L.
The investigation found that the duty to monitor Ms L’s lithium levels sat with the specialists at the hospital and not the Surgery. As Ms L’s lithium was stopped and re-started while she was in hospital, this was a new episode of prescribing and remained under specialist review. The onus on the Surgery was simply to carry out a blood test and submit it for review by those whose care Ms L was under in hospital.
The investigation also found that whilst there was an error by the Surgery in Ms L’s prescription of quetiapine which meant she had to correct it herself, the Surgery addressed the matter thoroughly in its complaint response and identified 4 learning points that sought to ensure instances such as Ms L’s did not happen again.
Ms L’s complaints were not upheld.